Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 1
2015 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy.
Debiec H, Valayannopoulos V, Boyer O, Nöel LH, Callard P, Sarda H, de Lonlay P, Niaudet P, Ronco P. Debiec H, et al. J Am Soc Nephrol. 2014 Apr;25(4):675-80. doi: 10.1681/ASN.2013030290. Epub 2013 Nov 21. J Am Soc Nephrol. 2014. PMID: 24262793 Free PMC article.
ERT was resumed 8 weeks after starting immunosuppressive therapy without inducing a rebound of antibody titer or an increase in proteinuria. We conclude that the allo-immune response to the recombinant rhASB caused the nephropathy. Considering the critical re …
ERT was resumed 8 weeks after starting immunosuppressive therapy without inducing a rebound of antibody titer or an increase in proteinuria. …
[Anti-CD 10 maternal-fetal allo-immunisation].
Ronco P, Debiec H. Ronco P, et al. Bull Acad Natl Med. 2012 Nov;196(8):1613-22; discussion 1622-3. Bull Acad Natl Med. 2012. PMID: 24313016 Free article. French.
Maternal-fetal alloimmunisation with antenatal glomerulopathies (FMAIG) is a recently described allo-immune disorder that results from the production of maternal antibodies which cross the placenta, bind to fetal glomerular podocytes and thereby cause renal dysfunct …
Maternal-fetal alloimmunisation with antenatal glomerulopathies (FMAIG) is a recently described allo-immune disorder that resu …
[Pathophysiology of extramembranous glomerulopathies. Fifty years of progress, from laboratory to patient].
Ronco P, Debiec H. Ronco P, et al. Biol Aujourdhui. 2013;207(4):249-59. doi: 10.1051/jbio/2013025. Epub 2014 Mar 5. Biol Aujourdhui. 2013. PMID: 24594573 Review. French.
Membranous nephropathy (MN) is a kidney disease characterized by deposition of immune complexes and complement on the outer aspect of the glomerular capillary wall. ...This finding points to a possible role of food and environmental antigens in membranous …
Membranous nephropathy (MN) is a kidney disease characterized by deposition of immune complexes and complement on the o …
[Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
Pozdzik AA, Debiec H, I Brochériou, Husson C, Rorive S, Broeders N, Le Moine A, Ronco P, Nortier J. Pozdzik AA, et al. Rev Med Brux. 2015 May-Jun;36(3):166-71. Rev Med Brux. 2015. PMID: 26372979 Review. French.
Membranous nephropathy (MN) is the most common cause for nephrotic syndrome in adults and occurs as an idiopathic (primary) or secondary disease. ...The neutral endopeptidase (NEP) and the receptor for secretory phospholipase A2 (PLA2R) have been identified as targe …
Membranous nephropathy (MN) is the most common cause for nephrotic syndrome in adults and occurs as an idiopathic (primary) or …